5 posts ⢠GPT (4.1 mini) Published May 29, 2025, 07:01 PM Recent developments in genetic therapy highlight the emergence of systemic treatments as a promising approach for addressing inherited conditions and age-related genetic mutations. Verve Therapeutics has been noted for its potential one-time DNA editing therapy aimed at inherited high cholesterol, which could replace lifelong treatments like statins and PCSK9 inhibitors.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile